Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
更正:甲磺酸伊马替尼(格列卫;STI571)治疗复发性少突胶质细胞瘤和混合型少突星形细胞瘤的 I/II 期试验。北美中部癌症治疗组研究 N0272 (ALLIANCE/NCCTG)
期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-019-03201-3
Jaeckle, Kurt A; Anderson, S K; Twohy, Erin L; Dixon, Jesse G; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J; Sarkaria, Jann N; Brown, Paul D; Flynn, P J; Schwerkoske, John; Buckner, Jan C; Galanis, Evanthia